Life Science

Our attitude towards this sector is distinguished by deep specialization in matters of life science. We help build and protect healthcare and life science companies through our extensive background in regulatory, intellectual property, licensing, litigation, product liability, unfair competition, antitrust, merger and acquisition, and other matters. Our comprehensive legal services are complemented by close collaboration with other professionals, within and outside the firm, in order to provide our clients with well-rounded and commercially focused service.
Key projects in the field

Key contact

Miglė Petkevičienė

Senior Associate

+370 52681828
crypt:PGEgY2xhc3M9ImVtYWlsIiBocmVmPSJtYWlsdG86bWlnbGUucGV0a2V2aWNpZW5lQGVsbGV4Lmx0Ij5taWdsZS5wZXRrZXZpY2llbmVAZWxsZXgubHQ8L2E+:xx
What's new in the field
Ellex Valiunas has been an exclusive legal and content partner of Life Science Baltics Report 2014, international forum of life sciences.

Key projects in the field

We helped global healthcare company Fresenius Kabi Group to transfer its pharmaceutical distribution business to Lithuania.
We advised Fresenius Kabi Polska and its Baltic subsidiary on transfer of its distribution operations from Poland to Lithuania. Fresenius Kabi Baltics went on to become the developer of distribution businesses in Lithuania, Latvia and Estonia. Our team assisted the client in structuring the transaction, including advice on tax issues.
We assisted global pharmaceutical company Novartis on a complex transaction with the Lithuanian Insurance Fund.
We helped Novartis to conclude a complex cost-volume agreement with the Lithuanian Insurance Fund in the framework of reimbursable medicine scheme.  The advice was provided during negotiation, drafting and enforcement. This transaction is one of the few with the Lithuanian Insurance Fund.
Normally, these types of transactions are non-negotiable and are concluded on “take or leave” principle. However, in this instance we have been successful in achieving what none have managed before. The complexity of the existing regulation also required extensive knowledge of pharmacy law and regulation.
We also advised Novartis on broader issues – regulatory (pharmacy), IP, employment and contract law matters.
We assisted Teva Pharmaceutical Industries, the world’s largest generic drug producer, on matters of intellectual property
Our team represented Teva Pharmaceutical Industries at the State Patent Bureau of Lithuania in a complicated trademark infringement case. The issue was related to registration of a misleadingly similar trademark. We helped Teva to create a legal strategy for protection of their intellectual property rights both in the EU and in non-member countries as the disputed trademark was registered in multiple jurisdictions.
Our experts also provided a solution of multijurisdictional agreement, designed for use in a number of jurisdictions. Our aim was to take all possible steps to individualise our client’s products as widely as possible, to establish maximum distinctiveness of the trademarks and to exclude any possible threat of confusion with the products of other manufacturers.